Clinical Trials Logo

Amblyopia clinical trials

View clinical trials related to Amblyopia.

Filter by:
  • Withdrawn  
  • Page 1 ·  Next »

NCT ID: NCT04959422 Withdrawn - Amblyopia Clinical Trials

Assuring Ophthalmologic Follow up

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to quantify the improvement in completed ophthalmology referrals and quantify the number of children identified and treated for amblyopia or pre amblyopic strabismus resulting from the implementation of a new referral and tracking system.

NCT ID: NCT03919708 Withdrawn - Amblyopia Clinical Trials

Amblyopia and Strabismus Detection Using Retinal Birefringence Imaging

RBI
Start date: February 4, 2020
Phase:
Study type: Observational

The purpose of this project is to compare the accuracy of two products at detecting amblyopia and strabismus in children. The devices will be Rebiscan's "blinq" (Pediatric Vision Scanner; PVS) and Rebiscan's RBI (Retinal Birefringence Imager).

NCT ID: NCT03906994 Withdrawn - Amblyopia Clinical Trials

Treating Amblyopia in Adults With Interactive Video Games

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Researchers are trying to determine whether interactive video game play, while wearing a patch over better-seeing eye, will improve subject reduced vision (amblyopia).

NCT ID: NCT03402789 Withdrawn - Amblyopia Clinical Trials

Docosahexaenoic Acid (DHA) Supplementation in Amblyopia

Start date: January 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This study evaluates the addition of docosahexaenoic acid (DHA) to eye patching in the treatment of residual amblyopia in children ages 3 to 18 years old. Two thirds of participants will receive DHA along with eye patching, while one third of participants will receive a placebo along with eye patching.

NCT ID: NCT03342235 Withdrawn - Refractive Errors Clinical Trials

Excimer Laser Surgery for Anisometropic Amblyopia

ATS19
Start date: June 2020
Phase: N/A
Study type: Interventional

Study Objectives To compare the efficacy and safety of surgical treatment (PRK) versus non-surgical treatment of anisometropic amblyopia in children who have failed conventional treatment due to non-compliance or non-response. Synopsis of Study Design The study consists of two phases: 1. A Patching Run-In Phase during which all participants are treated for at least 8 weeks with continued refractive correction (with spectacles and/or contact lenses) and patching prescribed 42 hours per week (averaging 6 hours daily) until no further improvement over 2 consecutive visits at least 4 weeks apart or the vision no longer meets eligibility criteria. 2. A Randomized Trial Phase, beginning after no further VA improvement in the patching run-in phase and qualifying amblyopia is still present, during which the participant is assigned to either surgery with PRK and patching prescribed 2 hours per day or to non-surgical treatment with continued refractive correction (with spectacles and/or contact lenses) and patching prescribed 2 hours per day.

NCT ID: NCT03151200 Withdrawn - Amblyopia Clinical Trials

Visual Functional Connectivity and Visual Improvement After TMS/Binocular Treatment

Start date: January 30, 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effectiveness of combining binocular treatment with repetitive transcranial magnetic stimulation (rTMS) in improving the vision of adults with amblyopia. This study also seeks to assess the effect of this combined treatment on cortical neural function and functional connectivity.

NCT ID: NCT02799836 Withdrawn - Amblyopia Clinical Trials

The Effect of Light Deprivation on Visual Functions in Adult Amblyopes

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

Amblyopia is a significant health problem, affecting up to 4% of the population in the United States. Amblyopia, commonly known as "lazy eye," is a developmental visual disorder in which one or both eyes suffer from poor vision as a result of being disadvantaged in early life. Strabismus, or eye misalignment, such as crossed eyes (esotropia) or wandering eyes (exotropia), and anisometropia, or a power difference between the eyes, are the most common causes of amblyopia. If conventional treatment, such as patching the better seeing eye, is not initiated during the critical period of visual development, lasting visual impairment may persist throughout life. This critical period of visual development has been thought to end around age 10. However, recent research has demonstrated that the critical period of visual development can be extended into adulthood. Complete light deprivation in animal models has restored plasticity in the visual cortex and has demonstrated drastic recovery of vision in amblyopic eyes. The objective of this pilot study is to evaluate the impact of complete light deprivation on visual function in a cohort of human adults with severe amblyopia from anisometropia.

NCT ID: NCT02655432 Withdrawn - Cataract Clinical Trials

Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population

POPH
Start date: January 2016
Phase: Phase 0
Study type: Observational

Screening of haitian children between the ages of 3 and 6 years old for amblyogenic risk factors with the use of the Spot photoscreener. The photoscreener results will be compared to the complete ophthalmologic evaluation. Primarily, this will allow evaluation of the performance of the spot photoscreener in the haitian children population. Secondarily, this study will gather epidemiological information on vision problems in the haitian children population.

NCT ID: NCT02594358 Withdrawn - Amblyopia Clinical Trials

Caffeine in Amblyopia Study

CAS
Start date: October 2014
Phase: Phase 1/Phase 2
Study type: Interventional

Prospective data on the visual acuity response in children treated by patching concurrently treated with caffeine and estimate the magnitude of effect that might be seen in a randomized trial (if no improvement in acuity is seen, this would be sufficient evidence to decide not to conduct a randomized, double blind trial). Collect prospective data on the tolerability of caffeine in two dosages as an adjuvant treatment for amblyopia and provide limited data on its safety. Evaluate the potential for a dietary intervention to enhance the acceptance and tolerability of patching on the child and family. Demonstrate recruitment potential of subjects to participate in a dietary intervention study.

NCT ID: NCT02555384 Withdrawn - Clinical trials for Strabismic Amblyopia

AMblyopia Treatment Through PErceptual Training in Children (AMPEL)

AMPEL
Start date: January 2020
Phase: N/A
Study type: Interventional

Amblyopia, affects 4% of the population. In the presence of a normal retina and optic nerve, the visual cortex does not develop normally secondary to the amblyopic eye being at a disadvantage in the sensitive period such as in strabismus. Amblyopia is associated with visuospatial disorders, and poor to absent stereopsis. Amblyopia is treated by occlusion of the non- amblyopic eye in childhood. The present study aims to evaluate the effectiveness of perceptual learning (PL), that is a training of visual drawing tasks (12 sessions of 30 Minutes duration) with crowding (c) for children with amblyopia compared to an amblyopic control group with a placebo drawing task. Arm 1: Crowded (PLc)- Training with small spacing Arm 2: Uncrowded (PLu)- Training with large spacing Prior to this, a small group will help optimize parameters such as contrast and distance of visual objects presented